Abecarnil, a new beta-carboline, in the treatment of anxiety disorders
Data up to Jan 2025
Total Citations Per Year
Abstract
References (26)
THE ASSESSMENT OF ANXIETY STATES BY RATING
1959 • 10,517 citations
REPLICATION OF FACTORS OF PSYCHOPATHOLOGY IN INTERVIEW, WARD BEHAVIOR AND SELF-REPORT RATINGS OF HOSPITALIZED DEPRESSIVES
1969 • 384 citations
User's guide for the Structured clinical interview for DSM-III-R : SCID
1990 • 352 citations
Long-term Therapeutic Use of Benzodiazepines
1990 • 318 citations
The empirical basis of generalized anxiety disorder
1994 • 315 citations
The benzodiazepines: from molecular biology to clinical practice
1984 • 293 citations
Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment
1984 • 178 citations
The association between premenstrual dysphoric disorder and other mood disorders.
1997 • 155 citations
Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.
1990 • 130 citations
ZK 91296, a partial agonist at benzodiazepine receptors
1984 • 107 citations
Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.
1990 • 84 citations
?-Carbolines can enhance or antagonize the effects of punishment in mice
1985 • 82 citations
Comparative Assessment of Efficacy and Withdrawal Symptoms After 6 and 12 Weeks' Treatment with Diazepam or Buspirone
1989 • 74 citations
Placebo response in generalized anxiety: its effect on the outcome of clinical trials.
1997 • 62 citations
Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.
1995 • 59 citations
Benzodiazepines
1994 • 52 citations
The dependence potential of short half-life benzodiazepines: a meta-analysis.
1993 • 51 citations
PRIMARY DEPRESSION OR PRIMARY ANXIETY? A POSSIBLE PSYCHOMETRIC APPROACH TO A DIAGNOSTIC DILEMMA
1984 • 40 citations
A Double-Blind Evaluation of the Safety and Efficacy of Abecarnil, Alprazolam, and Placebo in Outpatients With Generalized Anxiety Disorder
1997 • 38 citations
Abecarnil is a Full Agonist at Some, and a Partial Agonist at Other Recombinant GABAA Receptor Subtypes
1993 • 35 citations
Human studies on abecarnil a new beta‐carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.
1993 • 26 citations
Clinical perspectives of β-carbolines from first studies in humans
1987 • 25 citations
Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
1997 • 22 citations
A Comparative Study of Suriclone, Lorazepam and Placebo in Anxiety Disorder
1989 • 22 citations
Abecarnil: A Novel Anxiolytic with Mixed Full Agonist/Partial Agonist Properties in Animal Models of Anxiety and Sedation
1993 • 19 citations
[Treatment of generalized anxiety: new pharmacologic approaches].
1995 • 6 citations